Machine signal
Active cluster sell — 7 distinct insiders, $208.5M, window ends Sep 30, 2026.
Figures computed from official regulatory filings — .
Analysttarget 589.92 USD (-5%) · consensus 3.07/5 · 2 buy · 11 hold · 1 sell
Ownershipinsiders 18.91% · institutions 91.19% · short 7.5% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Medpace Holdings, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
40 buys514 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Kraft Robert O.track record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Kraft Robert O.track record | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Carley Brian T | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| McCarthy Cornelius P. III | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Carley Brian T | Exercise | n/a (No price was disclosed in the filing) | SEC |
| McCarthy Cornelius P. III | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Troendle August J.track record | Sell | $16.6M | SEC |
| Troendle August J.track record | Sell | $13.7M | SEC |
| Troendle August J.track record | Sell | $1.5M | SEC |
| Troendle August J.track record | Sell | $95.6K | SEC |
| Troendle August J.track record | Sell | $10.1M | SEC |
| Troendle August J.track record | Sell | $17.3M | SEC |
| Troendle August J.track record | Sell | $13.6M | SEC |
| Troendle August J.track record | Sell | $30.8M | Unusual size | SEC |
| Troendle August J.track record | Sell | $6.7M | SEC |
| BURWIG SUSAN E | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Troendle August J.track record | Sell | $9.9M | SEC |
| Troendle August J.track record | Sell | $5.4M | SEC |
| BURWIG SUSAN E | Exercise | $500.2K | SEC |
| Troendle August J.track record | Sell | $403.2K | SEC |
| Kraft Robert O.track record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Kraft Robert O.track record | Sell | $2.4M | SEC |
| Kraft Robert O.track record | Exercise | $325.5K | Unusual size | SEC |
| Troendle August J.track record | Sell | $2.5M | SEC |
| Troendle August J.track record | Sell | $417.5K | SEC |